Stonebridge Ventures has sold part of its Livesmed stake via block deal to a global long-only fund, aiming to stabilize shareholder structure and minimize overhang risk.
#YonhapInfomax #StonebridgeVentures #Livesmed #BlockDeal #LongOnlyFund #ShareholderStructure #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=101753

Nota, an AI optimization firm backed by Stonebridge Ventures, has been selected to support Qualcomm's AI Hub, validating its global technology and accelerating its planned KOSDAQ IPO in H1 2025.
#YonhapInfomax #Nota #StonebridgeVentures #QualcommAIHub #NetsPresso #KOSDAQIPO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=51625

Stonebridge Ventures enters a new exit supercycle, achieving record returns and preparing for major IPOs across its portfolio, signaling robust growth in South Korea's venture capital market.
#YonhapInfomax
#StonebridgeVentures #ExitSupercycle #IPO #VentureCapital #RecordReturns
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=99718

South Korea’s Adel Inc. secures a landmark $1.04 billion global licensing deal with Sanofi for its Alzheimer’s drug candidate, marking the nation’s largest biotech tech export and underscoring investor confidence in Adel’s neurodegenerative disease research.
#YonhapInfomax
#AdelInc #Sanofi #AlzheimersDrug #LicensingDeal #StonebridgeVentures
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=95764

Korea Post has selected seven domestic venture capital firms to manage a ₩100 billion ($76 million) investment in the AI value chain, with final selections expected by year-end.
#YonhapInfomax #KoreaPost #VentureCapital #AIInvestment #StonebridgeVentures #KolonInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=90938

Stonebridge Ventures is entering its largest-ever exit cycle, driven by record returns from AI and biotech investments, with annual exit proceeds set to reach new highs and even greater results expected in 2025.
#YonhapInfomax #StonebridgeVentures #AI #IPO #ExitCycle #BiotechInvestments #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=89348

Connective, a medical AI deep-tech firm backed by Stonebridge Ventures, has been named a top next-generation unicorn in South Korea, accelerating its push into global healthcare markets with advanced orthopedic AI and robotics solutions.
#YonhapInfomax #Connective #StonebridgeVentures #AIHealthcare #UnicornCandidate #OrthopedicSolutions #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=86517

AI optimization firm Nota has cleared KOSDAQ’s preliminary review, paving the way for an IPO and a potential exit for major VC backer Stonebridge Ventures, which holds an 11.12% stake.
#YonhapInfomax #Nota #KOSDAQ #StonebridgeVentures #IPO #AIFunding #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=74819